期刊文献+

尿毒症患者血透前后血小板参数及血红蛋白测定临床意义 被引量:4

Clinical Meanings of Measurement of Urinaemia Patients'Parameters on Pletelet and Hemoglobin.
下载PDF
导出
摘要 目的观察血液透析对尿毒症患者血小板参数及血红蛋白的影响。方法用全自动血细胞分析仪检测健康人组和尿毒症组血透前后的PLT(血小板),MPV(血小板平均体积),PDW(血小板分布宽度)Hb(血红蛋白)。结果尿毒症组血透前与健康人组Hb、PLT、MPV、PDW差异非常显著,两者经t检验,P<0.01;尿毒症组血透前与血透后PLT、MPV、PDW、Hb差异显著,两者经t检验,P<0.01。讨论血液透析是一种有效的治疗手段,它可以影响尿毒症患者PLT、MPV、PDW、Hb,这对临床观察治疗有一定的意义。 Objective To observe changes on those parameters on pletelet and hemoglobin of urinaemia patients by treatments of dialysis . Methods candidators are divided into three groups respectively - a control group ,two case groups. The two case groups are consist of patients who are treated through dialysis on not . In the three groups, the parameters on pletelet , hemoglobin, MPV and PDW are measured on hemocytometer in our laboratory. Results Dramatic difference is made in the parameters on PLT , Hb, MPV and PDW between the formers of dialysis and the control group. ( P 〈 0. 01 ) ; great divergence is made between the former group of dialysis and the latter group of dialysis. Conclusions Dialysis is an effective treatment, which enable to effect the parameters on PLT ,Hb, MPV and PDW of urinaemia patients. Therefore, it is significant for clinical treatment.
作者 韩颖 刘瑞萍
出处 《医学研究杂志》 2007年第1期84-85,共2页 Journal of Medical Research
关键词 血液透析 尿毒症 PLT MPV PDW Hb Dialysis Urinaemia Pletelet MPV PDW Hemoglobin
  • 相关文献

参考文献3

  • 1叶应妩,王毓三主编,中华人民共和国卫生部医政司编..全国临床检验操作规程 第2版[M].南京:东南大学出版社,1997:621.
  • 2叶任高..肾脏病诊断与治疗学[M].北京:人民卫生出版社,1999:752.
  • 3王淑咸 吴介平.肾脏病学[M].北京:人民卫生出版社,1991.682-683. 被引量:2

共引文献1

同被引文献22

  • 1陈扬,张淑芳.平均血小板体积检测的临床意义[J].中国热带医学,2005,5(5):1032-1032. 被引量:17
  • 2董芍芍,章圣泽.慢性肾功能不全患者外周血小板膜糖蛋白改变及其临床意义[J].江西医药,2005,40(10):639-640. 被引量:4
  • 3蔡小燕,潘学谊,黄华,张柔玲.尿毒症患者血浆凝血因子的变化及其临床意义[J].血栓与止血学,2006,12(2):70-72. 被引量:8
  • 4Levin J, Bessman JD. The inverse relation between platelet volume and platelet number. Abnormalities in hematologic disease and evidence that platelet size does not correlate with platelet age [J]. J Lab Clin Med, 1983,101:295- 307. 被引量:1
  • 5Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thremb Hemost,2004,30(5) :579 -589. 被引量:1
  • 6Liani M , Salvati F, Tresca E, et al. Arteriovenous fistula obstruc- tion and expressi on of platelet receptors for yon Willebrand factor and for fibrinogen (glyeopreteins GPIb and GPIIb/IIIa) in hemo- dialysis patients. Int J Artif Organs, 1996,19 ( 8 ) :451 - 454. 被引量:1
  • 7Kozek - Langenecker SA , Masaki T, Mohammad H, et al . Fi- brinogen fragments and platelct dysfunction in uremia. Kidney Int, 1999 ; 56:299. 被引量:1
  • 8Adriane C, Silva, Andre LB, et al. Enzymes that hydrolyze adenine nucleotides in chronic renal failure:Relationship between hemostat- ic defects and renal failure severity. Biochimica et Biophysica Aeta ,2005,1741:282 -288. 被引量:1
  • 9Dinkar K, Deepak M. Platelet Dysfunction and End - Stage Renal Disease. Seminam in Dialysis ,2006,19 (4) :317 - 322. 被引量:1
  • 10Rieger M, Mannueci PM, Kremer Hovinga JA, et al . AD- AMTS13 autoantibodies in patients with thrombotic microangiop- athies and other immunomediated diseases. Blood, 2005, 106 (4) : 1262 -1267. 被引量:1

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部